Atrial Septal Defect Clinical Trials

4 recruiting

Frequently Asked Questions

Common questions about Atrial Septal Defect clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting

Abbott Structural Heart Device Registry

Heart DiseasesValvular Heart DiseasePFO - Patent Foramen Ovale+3 more
Abbott Medical Devices2,500 enrolled27 locationsNCT06590467
Recruiting

Cerebral Microembolization Associated With PFO Closure

Atrial Septal DefectPatent Foramen Ovale (PFO)Thrombosis Cardiac
China National Center for Cardiovascular Diseases800 enrolled1 locationNCT06347276
Recruiting

Cera™ ASD Occluder Post-Market Clinical Follow-Up Study

Atrial Septal Defect
Lifetech Scientific (Shenzhen) Co., Ltd.139 enrolled6 locationsNCT06849635
Recruiting
Not Applicable

Efficacy of Three Dimensional Transesophageal Echocardiography for Percutaneous Device Closure in Atrial Septal Defect

Atrial Septal DefectSuccessful Device Closure
Asan Medical Center100 enrolled1 locationNCT02097758
Recruiting

Lifetech CeraFlex™ ASD Closure System Post-Market Clinical Follow-Up

Atrial Septal Defect
Lifetech Scientific (Shenzhen) Co., Ltd.145 enrolled7 locationsNCT05887700
Recruiting

Lifetech AcuMark™ Sizing Balloon Post-Market Clinical Follow-up Study

Atrial Septal Defect (ASD)
Lifetech Scientific (Shenzhen) Co., Ltd.100 enrolled5 locationsNCT06700174
Recruiting
Phase 4

Effect of Dexmedetomidine Supplementation to General Anaesthesia in Paediatric Transcatheter Closure of Atrial Septal Defect

DexmedetomidineDelirium - PostoperativeAtrial Septal Defect (ASD)+1 more
Alexandria University30 enrolled1 locationNCT06631534
Recruiting

Evaluation of the Effectiveness and Safety of Vibro-acoustic Pulmonary Therapy (VAPT) in Complex Therapy for Acute Respiratory Failure of Mixed Type I-II Stages in Comparison With Percussion Massage in Cardiac Surgical Patients in the Early Postoperative Period

Cardiac Surgical Patients (CABG,Mammary Coronary Bypass Surgery,Plastic and Replacement of Valves, Atrial Septal Defect,Ventricular Septal Defect)
Bark Technology LLP310 enrolled5 locationsNCT06320483